Salih Sanlioglu

11PUBLICATIONS
5CO-AUTHORS
Wastewater treatment processesMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Agricultural molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 11, 2026
Lentiviral GLP-1 gene therapy elicits developmental stage-dependent β-cell regeneration in diabetic rats.

|May 15, 2026
A Comprehensive Evaluation of CAR-T Cell Gene Therapy, Tracing its Revolutionary Clinical Breakthroughs and Advancements Towards Next-Generation Engineering.

|Apr 25, 2026
Advances in CRISPR Base Editing: From Molecular Evolution to Therapeutic Applications in Genomic Medicine.

|Mar 19, 2026
An Ad5-Based COVID-19 Vaccine Encoding SARS-CoV-2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice.

Fulya Erendor, Fatih Uzer, Salih Sanlioglu

|Nov 11, 2025
Lantidra (donislecel) in type 1 diabetes: An in-depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA-approved allogeneic islet cell therapy.

Ezgi Erbasan, Melike Aliciaslan, Fulya Erendor

|Oct 29, 2025
Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease.

Ezgi Erbasan, Melike Aliciaslan, Fulya Erendor

Pageof 2

Frequent Collaborators

3 joint publications

Fulya Erendor

2 joint publications

Melike Aliciaslan

2 joint publications

Ezgi Erbasan

1 joint publications

Mustafa Kemal Balci